Redormin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Redormin, covering 2024-01-11 to 2026-06-11. Get the full timeline:
Most recent: Clinical Trial Results: Feasibility Study on the Use of Redormin®500 on Day-time Cognition [Phase 4]